Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pliant Therapeutics Inc 331 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 USA

pliantrx.com Employees: 158 P: 650-481-6770

Description:

Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 853,782
Enterprise Value, $K 800,602
Shares Outstanding, K 60,854
Annual Sales, $ 1,580 K
Annual Net Income, $ -161,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -57,760 K
EBIT, $ -222,080 K
EBITDA, $ -225,230 K
60-Month Beta 1.05
% of Insider Shareholders 6.40%
% of Institutional Shareholders 97.30%
Float, K 56,959
% Float 93.60%
Short Volume Ratio 0.28

Growth:

1-Year Return -24.24%
3-Year Return 3.93%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 11/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -3.34
EPS Growth vs. Prev Qtr -3.26%
EPS Growth vs. Prev Year -35.71%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PLRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.91%
Return-on-Assets % -41.09%
Profit Margin % -10,211.39%
Debt/Equity 0.09
Price/Sales 519.57
Price/Cash Flow N/A
Price/Book 2.35
Book Value/Share 5.69
Interest Coverage -126.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar